The MDLive telehealth services available through Walgreens’ mobile application are now available to users in 25 states and promises better functionality and integration.
The MDLive telehealth services available through Walgreens’ mobile application are now available to users in 25 states and promises better functionality and integration.
Editor’s Choice: mHealth tools: A bond between patients and pharmacists
Additionally, Walgreens has launched its Walgreens Connect app, which allows Walgreens Balance Rewards members who own specific blood glucose testing and blood pressure monitoring systems to earn points for taking daily measurements.
The mobile app provides around-the-clock access to MDLIVE’s network of U.S. board-certified doctors.
“Walgreens provides convenient and connected services for our customers, and we are thrilled to be advancing our digital experience to provide patients with more choices when it comes to accessing care,” said Adam Pellegrini, Walgreens divisional vice president of digital health.
“We have seen that telehealth solutions play an important role in helping to improve patient outcomes, and we will continue to work to evolve our offerings to ensure our patients can choose what’s most convenient for them whether that’s live doctor consultations, digitally chatting with a pharmacist, or visiting a Healthcare Clinic,” he added.
Until now, the MDLive telehealth services were only available to Walgreens app users in California, Michigan, Colorado, Illinois, and Washington.
The services are now also available to users in Alabama, Arizona, California, Colorado, Connecticut, Florida, Indiana, Illinois, Iowa, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New York, North Carolina, Ohio, Oregon, South Carolina, Tennessee, Virginia, Washington, and Wisconsin.
For more on Walgreens, click here.
Examining Barriers to Care in Diabetic Retinopathy Screening
November 30th 2023Prior research has shown the association between various socioeconomic variables and lower adherence to diabetic retinopathy screening, but few have elaborated on the patient perspective to understand the reason behind this association.
Assessing a National Health Program to Prevent the Onset of Type 2 Diabetes in High-Risk Patients
November 16th 2023An analysis on the Diabetes Prevention Program in England found it was effective at improving key cardiovascular risk factors, including glycated hemoglobin and excess body weight.
AMCP Poster Suggests GLP-1, DPP4 Duplicative Prescribing Cutbacks to Reduce Drug Spending
November 4th 2023A poster presented at AMCP Nexus 2023 outlined how a Pharmacy Therapeutics program yielded $7,500 in savings per patient and $3.5 million in savings overall by reducing patients' incretin therapy prescriptions from two to one.